The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Injection Peptide Drug Market Research Report 2025
Synopsis
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
The global Injection Peptide Drug market was valued at US$ 35410 million in 2023 and is anticipated to reach US$ 62200 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.
This report aims to provide a comprehensive presentation of the global market for Injection Peptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Peptide Drug.
Report Scope
The Injection Peptide Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injection Peptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injection Peptide Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Segment by Type
Intravenous Injection
Subcutaneous Injection
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injection Peptide Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
The global Injection Peptide Drug market was valued at US$ 35410 million in 2023 and is anticipated to reach US$ 62200 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.
This report aims to provide a comprehensive presentation of the global market for Injection Peptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injection Peptide Drug.
Report Scope
The Injection Peptide Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injection Peptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injection Peptide Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Segment by Type
Intravenous Injection
Subcutaneous Injection
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injection Peptide Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injection Peptide Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Intravenous Injection
1.2.3 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Injection Peptide Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Injection Peptide Drug Market Perspective (2019-2030)
2.2 Injection Peptide Drug Growth Trends by Region
2.2.1 Global Injection Peptide Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Injection Peptide Drug Historic Market Size by Region (2019-2024)
2.2.3 Injection Peptide Drug Forecasted Market Size by Region (2025-2030)
2.3 Injection Peptide Drug Market Dynamics
2.3.1 Injection Peptide Drug Industry Trends
2.3.2 Injection Peptide Drug Market Drivers
2.3.3 Injection Peptide Drug Market Challenges
2.3.4 Injection Peptide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Injection Peptide Drug Players by Revenue
3.1.1 Global Top Injection Peptide Drug Players by Revenue (2019-2024)
3.1.2 Global Injection Peptide Drug Revenue Market Share by Players (2019-2024)
3.2 Global Injection Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Injection Peptide Drug Revenue
3.4 Global Injection Peptide Drug Market Concentration Ratio
3.4.1 Global Injection Peptide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injection Peptide Drug Revenue in 2023
3.5 Injection Peptide Drug Key Players Head office and Area Served
3.6 Key Players Injection Peptide Drug Product Solution and Service
3.7 Date of Enter into Injection Peptide Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Injection Peptide Drug Breakdown Data by Type
4.1 Global Injection Peptide Drug Historic Market Size by Type (2019-2024)
4.2 Global Injection Peptide Drug Forecasted Market Size by Type (2025-2030)
5 Injection Peptide Drug Breakdown Data by Application
5.1 Global Injection Peptide Drug Historic Market Size by Application (2019-2024)
5.2 Global Injection Peptide Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Injection Peptide Drug Market Size (2019-2030)
6.2 North America Injection Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Injection Peptide Drug Market Size by Country (2019-2024)
6.4 North America Injection Peptide Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Injection Peptide Drug Market Size (2019-2030)
7.2 Europe Injection Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Injection Peptide Drug Market Size by Country (2019-2024)
7.4 Europe Injection Peptide Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Injection Peptide Drug Market Size (2019-2030)
8.2 Asia-Pacific Injection Peptide Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Injection Peptide Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Injection Peptide Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Injection Peptide Drug Market Size (2019-2030)
9.2 Latin America Injection Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Injection Peptide Drug Market Size by Country (2019-2024)
9.4 Latin America Injection Peptide Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Injection Peptide Drug Market Size (2019-2030)
10.2 Middle East & Africa Injection Peptide Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Injection Peptide Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Injection Peptide Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Injection Peptide Drug Introduction
11.1.4 Sanofi Revenue in Injection Peptide Drug Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Injection Peptide Drug Introduction
11.2.4 Teva Revenue in Injection Peptide Drug Business (2019-2024)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Injection Peptide Drug Introduction
11.3.4 Novo Nordisk Revenue in Injection Peptide Drug Business (2019-2024)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Injection Peptide Drug Introduction
11.4.4 Takeda Revenue in Injection Peptide Drug Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Detail
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Injection Peptide Drug Introduction
11.5.4 Eli Lilly Revenue in Injection Peptide Drug Business (2019-2024)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Injection Peptide Drug Introduction
11.6.4 AstraZeneca Revenue in Injection Peptide Drug Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Injection Peptide Drug Introduction
11.7.4 Novartis Revenue in Injection Peptide Drug Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Injection Peptide Drug Introduction
11.8.4 AbbVie Revenue in Injection Peptide Drug Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Detail
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Injection Peptide Drug Introduction
11.9.4 Ipsen Revenue in Injection Peptide Drug Business (2019-2024)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Detail
11.10.2 Ferring Business Overview
11.10.3 Ferring Injection Peptide Drug Introduction
11.10.4 Ferring Revenue in Injection Peptide Drug Business (2019-2024)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Detail
11.11.2 Merck Business Overview
11.11.3 Merck Injection Peptide Drug Introduction
11.11.4 Merck Revenue in Injection Peptide Drug Business (2019-2024)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Detail
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Injection Peptide Drug Introduction
11.12.4 The Medicines Revenue in Injection Peptide Drug Business (2019-2024)
11.12.5 The Medicines Recent Development
11.13 J & J
11.13.1 J & J Company Detail
11.13.2 J & J Business Overview
11.13.3 J & J Injection Peptide Drug Introduction
11.13.4 J & J Revenue in Injection Peptide Drug Business (2019-2024)
11.13.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Injection Peptide Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Intravenous Injection
Table 3. Key Players of Subcutaneous Injection
Table 4. Global Injection Peptide Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Injection Peptide Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Injection Peptide Drug Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Injection Peptide Drug Market Share by Region (2019-2024)
Table 8. Global Injection Peptide Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Injection Peptide Drug Market Share by Region (2025-2030)
Table 10. Injection Peptide Drug Market Trends
Table 11. Injection Peptide Drug Market Drivers
Table 12. Injection Peptide Drug Market Challenges
Table 13. Injection Peptide Drug Market Restraints
Table 14. Global Injection Peptide Drug Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Injection Peptide Drug Market Share by Players (2019-2024)
Table 16. Global Top Injection Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2023)
Table 17. Ranking of Global Top Injection Peptide Drug Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Injection Peptide Drug Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Injection Peptide Drug Product Solution and Service
Table 21. Date of Enter into Injection Peptide Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Injection Peptide Drug Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Injection Peptide Drug Revenue Market Share by Type (2019-2024)
Table 25. Global Injection Peptide Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Injection Peptide Drug Revenue Market Share by Type (2025-2030)
Table 27. Global Injection Peptide Drug Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Injection Peptide Drug Revenue Market Share by Application (2019-2024)
Table 29. Global Injection Peptide Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Injection Peptide Drug Revenue Market Share by Application (2025-2030)
Table 31. North America Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Injection Peptide Drug Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Injection Peptide Drug Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Injection Peptide Drug Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Injection Peptide Drug Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Injection Peptide Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Injection Peptide Drug Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Injection Peptide Drug Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Injection Peptide Drug Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Injection Peptide Drug Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Injection Peptide Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Injection Peptide Drug Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Injection Peptide Drug Market Size by Country (2025-2030) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Injection Peptide Drug Product
Table 49. Sanofi Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Teva Company Detail
Table 52. Teva Business Overview
Table 53. Teva Injection Peptide Drug Product
Table 54. Teva Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 55. Teva Recent Development
Table 56. Novo Nordisk Company Detail
Table 57. Novo Nordisk Business Overview
Table 58. Novo Nordisk Injection Peptide Drug Product
Table 59. Novo Nordisk Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 60. Novo Nordisk Recent Development
Table 61. Takeda Company Detail
Table 62. Takeda Business Overview
Table 63. Takeda Injection Peptide Drug Product
Table 64. Takeda Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 65. Takeda Recent Development
Table 66. Eli Lilly Company Detail
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Injection Peptide Drug Product
Table 69. Eli Lilly Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. AstraZeneca Company Detail
Table 72. AstraZeneca Business Overview
Table 73. AstraZeneca Injection Peptide Drug Product
Table 74. AstraZeneca Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 75. AstraZeneca Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Injection Peptide Drug Product
Table 79. Novartis Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. AbbVie Company Detail
Table 82. AbbVie Business Overview
Table 83. AbbVie Injection Peptide Drug Product
Table 84. AbbVie Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. Ipsen Company Detail
Table 87. Ipsen Business Overview
Table 88. Ipsen Injection Peptide Drug Product
Table 89. Ipsen Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 90. Ipsen Recent Development
Table 91. Ferring Company Detail
Table 92. Ferring Business Overview
Table 93. Ferring Injection Peptide Drug Product
Table 94. Ferring Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 95. Ferring Recent Development
Table 96. Merck Company Detail
Table 97. Merck Business Overview
Table 98. Merck Injection Peptide Drug Product
Table 99. Merck Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 100. Merck Recent Development
Table 101. The Medicines Company Detail
Table 102. The Medicines Business Overview
Table 103. The Medicines Injection Peptide Drug Product
Table 104. The Medicines Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 105. The Medicines Recent Development
Table 106. J & J Company Detail
Table 107. J & J Business Overview
Table 108. J & J Injection Peptide Drug Product
Table 109. J & J Revenue in Injection Peptide Drug Business (2019-2024) & (US$ Million)
Table 110. J & J Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injection Peptide Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Injection Peptide Drug Market Share by Type: 2023 VS 2030
Figure 3. Intravenous Injection Features
Figure 4. Subcutaneous Injection Features
Figure 5. Global Injection Peptide Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Injection Peptide Drug Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Metabolic Disorders Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Other Case Studies
Figure 11. Injection Peptide Drug Report Years Considered
Figure 12. Global Injection Peptide Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Injection Peptide Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Injection Peptide Drug Market Share by Region: 2023 VS 2030
Figure 15. Global Injection Peptide Drug Market Share by Players in 2023
Figure 16. Global Top Injection Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Peptide Drug as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Injection Peptide Drug Revenue in 2023
Figure 18. North America Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Injection Peptide Drug Market Share by Country (2019-2030)
Figure 20. United States Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Injection Peptide Drug Market Share by Country (2019-2030)
Figure 24. Germany Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Injection Peptide Drug Market Share by Region (2019-2030)
Figure 32. China Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Injection Peptide Drug Market Share by Country (2019-2030)
Figure 40. Mexico Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Injection Peptide Drug Market Share by Country (2019-2030)
Figure 44. Turkey Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Injection Peptide Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Sanofi Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 47. Teva Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 48. Novo Nordisk Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 49. Takeda Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 50. Eli Lilly Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 51. AstraZeneca Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 53. AbbVie Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 54. Ipsen Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 55. Ferring Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 57. The Medicines Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 58. J & J Revenue Growth Rate in Injection Peptide Drug Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
